Status:
COMPLETED
Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis
Lead Sponsor:
Fundação Altino Ventura
Conditions:
Conjunctivitis, Viral
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared ...
Detailed Description
The purpose of this study is to evaluate the evolution of the symptoms of acute viral conjunctivitis using preservative free ketorolac trometamol 0.45% associated with carboxymethylcellulose compared ...
Eligibility Criteria
Inclusion
- Acute conjunctivitis (unilateral or bilateral) for less than two weeks,
- Signs and symptoms consistent with viral conjunctivitis and at least one of the following: preauricular lymphadenopathy, upper tract respiratory infection or recent contact with someone with conjunctivitis
Exclusion
- pregnant women
- allergies to non-steroidal anti-inflammatories
- history of seasonal allergic conjunctivitis
- contact lens wearers
- history of ocular herpes infection
- blepharitis
- severe dry eye
- purulent discharge
- defects in the corneal epithelium
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01799863
Start Date
June 1 2012
End Date
March 1 2013
Last Update
April 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundação Altino Ventura
Recife, Pernambuco, Brazil, 50070040